Penserra Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Sell |
1,934
-1,249
| -39% | -$87.2K | ﹤0.01% | 696 |
|
|
2025
Q1 | $233K | Buy |
3,183
+226
| +8% | +$16.5K | ﹤0.01% | 715 |
|
|
2024
Q4 | $193K | Sell |
2,957
-169
| -5% | -$11K | ﹤0.01% | 752 |
|
|
2024
Q3 | $243K | Sell |
3,126
-27,717
| -90% | -$2.15M | 0.01% | 678 |
|
|
2024
Q2 | $2.41M | Buy |
30,843
+22,663
| +277% | +$1.77M | 0.03% | 332 |
|
|
2024
Q1 | $554K | Sell |
8,180
-3,768
| -32% | -$255K | 0.01% | 561 |
|
|
2023
Q4 | $804K | Buy |
11,948
+1,848
| +18% | +$124K | 0.02% | 414 |
|
|
2023
Q3 | $683K | Buy |
10,100
+4,960
| +96% | +$335K | 0.01% | 430 |
|
|
2023
Q2 | $367K | Buy |
5,140
+1,510
| +42% | +$108K | 0.01% | 624 |
|
|
2023
Q1 | $251K | Sell |
3,630
-39,295
| -92% | -$2.72M | 0.01% | 644 |
|
|
2022
Q4 | $2.91M | Buy |
42,925
+42,295
| +6,713% | +$2.87M | 0.06% | 296 |
|
|
2022
Q3 | $34K | Sell |
630
-17,267
| -96% | -$932K | ﹤0.01% | 855 |
|
|
2022
Q2 | $1.18M | Buy |
+17,897
| New | +$1.18M | 0.03% | 370 |
|